Recommendation ID
NG198/2
Question

What is the most effective first-line treatment option for any severity of acne vulgaris for people with polycystic ovary syndrome?

Any explanatory notes
(if applicable)

For a short explanation of why the committee made the recommendation for research, see the rationale section on treatment options for people with polycystic ovary syndrome .

Full details of the evidence and the committee's discussion are in evidence review G: management options for people with acne vulgaris and polycystic ovary syndrome.


Source guidance details

Comes from guidance
Acne vulgaris: management
Number
NG198
Date issued
June 2021

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 01/01/2024